Stomach diseases

A new generation of PPI are presently in clinical trials. They are characterized by a quicker and longer effectiveness, very useful for reflux disease treatment. We have to note that the enthusiasm towards the endoscopy treatment for reflux disease is clearly deceasing and two types of procedures ha...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Revue médicale suisse 2006-01, Vol.2 (49), p.182
Hauptverfasser:	Nichita, C, Viani, F, Vouillamoz, F, Jornod, P, Kessler-Brondolo, V, Dorta, G
Format:	Artikel
Sprache:	fre
Schlagworte:	Clinical Trials as Topic Cyclooxygenase 2 Inhibitors - adverse effects Cyclooxygenase 2 Inhibitors - therapeutic use Enzyme Inhibitors - therapeutic use Esophageal Diseases - physiopathology Esophageal Diseases - therapy Helicobacter Infections - drug therapy Humans Proton Pump Inhibitors Risk Factors Stomach Diseases - physiopathology Stomach Diseases - therapy Stomach Ulcer - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!